Cabergoline 20tab/50mcg Cabergoline – Magnus

Magnus Cabergoline is a pharmaceutical-grade dopamine agonist categorized as an Anti-Estrogen / AI. It’s primarily used by bodybuilders and strength athletes for research purposes to manage elevated prolactin levels, which can occur during or after cycles involving anabolic steroids. Users report that consistent dosing with Magnus Cabergoline helps maintain hormonal balance, supports libido, and aids in post-cycle recovery. This product contains 20 tablets of 50µg each, offering precise control over dosage.

Cabergoline is a potent D2 receptor agonist. It works by inhibiting the release of prolactin from the pituitary gland. Elevated prolactin can lead to gynecomastia (male breast tissue development) and other undesirable side effects during anabolic steroid use. By reducing prolactin levels, Cabergoline helps mitigate these issues. For research purposes, it’s often incorporated into post-cycle therapy (PCT) protocols. The compound's effectiveness stems from its ability to bind strongly to dopamine receptors, leading to a sustained reduction in prolactin secretion. Athletes typically utilize cabergoline when running compounds known for their prolactin-raising effects.

Users report several benefits from incorporating Magnus Cabergoline into their research protocols. Firstly, it facilitates rapid prolactin reduction, which can be crucial for post-cycle recovery and minimizing estrogenic side effects. Secondly, it supports hormonal balance by addressing imbalances caused by anabolic steroid use. Thirdly, many athletes experience improved libido and mood stability when managing prolactin levels effectively. Finally, the consistent 50µg dosage per tablet allows for precise control and optimization of research outcomes. Magnus Cabergoline is known within the bodybuilding community for its high purity and reliable effects.

Cabergoline is not typically stacked with other compounds but rather used strategically as needed. It’s commonly paired with Selective Estrogen Receptor Modulators (SERMs) like Clomiphene Citrate or Tamoxifen Citrate during PCT to address both estrogen and prolactin imbalances. Athletes typically run cabergoline alongside SERMs for a comprehensive post-cycle approach. Combining it with aromatase inhibitors is generally not recommended unless specifically indicated by research protocols, as this can lead to excessively low estrogen levels. It’s crucial to monitor hormone levels closely when combining multiple compounds.

Cabergoline is a potent compound and should be used responsibly for research purposes only. Common side effects reported by users include nausea, dizziness, and headaches. More serious, but less frequent, side effects may include hypotension (low blood pressure) and impulse control disorders. It’s essential to start with a low dose and gradually increase it as needed, monitoring for any adverse reactions. A post-cycle therapy (PCT) protocol is highly recommended after completing cycles where cabergoline is used. Regular blood work is crucial to assess prolactin levels and overall hormonal status.

Users report that cabergoline dosing is highly individualized, depending on the compounds used during the cycle and individual prolactin response. Athletes typically run it in cycles ranging from several weeks to several months, adjusting dosage based on blood work results. It’s crucial to monitor prolactin levels throughout the cycle to optimize effectiveness.

⚠️ Safety

• Cabergoline can cause hypotension (low blood pressure); monitor your blood pressure regularly.
• Long-term use of high doses may lead to impulse control disorders; be aware of any behavioral changes.
• This compound is not intended for use by individuals under the age of 21.